¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"haematoxylin bodies"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Aschoff bodies
    ¾Æ¼îÇÁ¼Òü
  • Cabot ring bodies
    Ä«º¸Æ®°í¸®¼Òü
  • Cowdry type A inclusion bodies
    Ä«¿ìµå¸®AÇüÆ÷ÇÔü, Ä«¿ìµå¸®AÇüºÀÀÔü
  • Cowdry type B inclusion bodies
    Ä«¿ìµå¸®BÇüÆ÷ÇÔü, Ä«¿ìµå¸®BÇüºÀÀÔü
  • Call-Exner bodies
    Ä®-¿¢½º³Ê¼Òü
  • Guarnieri¡¯s bodies
    °ú¸£´Ï¿¡¸®Æ÷ÇÔü, °ú¸£´Ï¿¡¸®ºÀÀÔü
  • Heinz bodies
    ÇÏÀÎÃ÷¼Òü
  • Howell-Jolly bodies
    ÇÏ¿ù-Á¹¸®¼Òü
  • Mallory bodies
    ¸È·Î¸®¼Òü
  • Negri bodies
    ³×±×¸®¼Òü
  • Russell¡¯s bodies
    ·¯¼¿¼Òü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Ketone bodies
    ÄÉÅæÃ¼(¡­ô÷)
  • Negri bodies
    ³×±×¸®¼Òü ±¤°ßº´ºÀÀÔ¼Òü .
  • Nissls bodies
    ´Ï½½¼Òü.
  • amyloid bodies<³ª> corpora amylacea
    ¾Æ¹Ð·ÎÀ̵å¼Òü(¡­á³ô÷).
  • guarneri bodies
    Guarneri ¼Òü
  • quadrigeminal bodies
    »ç±¸Ã¼(ÞÌÎøô÷).
  • quadrigeminal bodies
    ȍ
  • removal of foreign bodies in root canal
    ±Ù°ü³»À̹°Á¦°Å¹ý(ÐÆÎ·Ò®ì¶Úªð¶ËÛ Ûö).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amyloid bodies<³ª> corpora amylacea
    ¾Æ¹Ð·ÎÀ̵å¼Òü(¡­á³ô÷).
  • civatte bodies
    ½Ã¹ÙƮü(¡­ô÷)
  • cystoid bodies
    ¼¼Æ÷¾ç¼Òü
  • dense bodies
    Ä¡¹Ð¼Òü(öÆÚËá³ô÷)
  • doehle bodies
    Doehle¼Òü
  • electron dense bodies
    ÀüÀڹеµ¼Òü
  • elementary bodies
    ±âº»¼Òü
  • foreign bodies
    À̹°(ì¶Úª)
  • guarneri bodies
    Guarneri ¼Òü
  • hx bodies
    HX ¼Òü
  • hx bodies,in histiocytosis x
    Á¶Á÷±¸Áõ X
  • intraneuronal bodies
    ½Å°æ¿ø³»¼Òü(ãêÌèê­Ò® á³ô÷)
  • leukemia,auer bodies or rods
    ¾Æ¿ì¿¡¸£ ¼Òü(á³ô÷) ¶Ç´Â ¾Æ¿ì¿¡¸£ °£
  • negri bodies
    ³×±×¸®¼Òü ±¤°ßº´ºÀÀÔ¼Òü(ÎÊÌ³Ü»Üæìýá³ô÷)
  • picks bodies
    ÇÇÅ©¼Òü(¡­á´ô÷)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • herring bodies
    Ç층ü(ô÷)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
ASAB Anti-Sperm Anti-Bodies
HJ Howell-Jolly [bodies]
P/I/X patients, indicators, external bodies
UFB urinary fat bodies
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
H&E Haematoxylin Eosin
H&E Haematoxylin and Eosin
HBFP Haematoxylin--Basic Fuchsin--picric acid
HE Haematoxylin-Eosin
AB Asbestos bodies
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • bodies of Arantius
    ¾Æ¶õƼ¿ì½º °áÀý
    ´ëµ¿¸ÆÆÇÀÇ °áÀý.
  • Cabot's ring bodies
    Ä«º¸Æ® ȯ»óü
    ÁßÁõ ºóÇ÷ ȯÀÚÀÇ ÀûÇ÷±¸¿¡¼­ º¼ ¼ö Àִ ȯ»ó ¶Ç´Â 8ÀÚÇüÀÇ ¼±À̸ç, Wright-Leishman ¿°»öü¿¡¼­ Àû»öÀ¸·Î, ¿°È­ ¸ÞƿŸÀÌ¿À´ÑÀÇ ¿¡¿À»êÈ­¹° ¿°»ö¿¡¼­ û»öÀ¸·Î ¿°»öµÈ´Ù.
  • Doehle bodies
    Doehle ¼Òü
  • fibrin bodies of pleura
    È丷 ¼¶À¯ ¼Òü
    È丷°­ ±âÀúºÎ±Ù¿¡ ÀÖ´Â °¡µ¿¼º ¶Ç´Â Á¡Âø¼º, ±¸»ó, µ¿Áú¼º, ±×¸®°í ÇѰ谡 ¸íÈ®ÇÑ À¯¹éü·Î¼­, È丷 »ïÃâ¾×, ±âÈä ¶Ç´Â Ç÷±âÈäÁõ¿¡¼­ ÀÌÂ÷ÀûÀ¸·Î ¹ß»ýÇÑ´Ù.
  • Herring bodies
    Ç층 ¼Òü
    Çϼöü ½Å°æºÎ¿¡ Á¸ÀçÇÏ´Â ÃÊÀÚÁú ¶Ç´Â ±³ÁúÀÇ µ¢¾î¸®.
  • inclusion bodies
    ºÀÀÔü, ºÀÀÔ ¼Òü
    ¼¼Æ÷ÀÇ ¼¼Æ÷Áú ³»Áö ÇÙÁú ³»¿¡ ³ªÅ¸³ª´Â ±¸Çü ¶Ç´Â ³­ÇüÀÇ ºÒ±ÔÄ¢ÇÑ ¼ÒüÀ̸ç, ±¤°ßº´, µÎâ, ÇãÇǽº¿Í °°Àº ¿©°ú¼º ¹ÙÀÌ·¯½º¿¡ ÀÇÇÑ °¨¿°Áõ¿¡¼­ º¼ ¼ö ÀÖ´Ù.
  • Leishman-Donovan bodies
    ·¹½´¸¸-µµ³ë¹Ýü
    Ä®¶ó-¾ÆÀÚ¸£ º´¿¡ °É¸° ȯÀÚÀÇ Æ¯È÷ ºñÀå°ú °£ÀÇ ¼¼¸Á ³»ÇÇ ¼¼Æ÷ ³»¿¡¼­ °üÂûµÇ´Â ±¸Çü ¶Ç´Â ³­ÇüÀÇ ¼Òü·Î¼­, ÀÌ º´À» ÀÏÀ¸Å°´Â ±â»ýÃæÀÎ ¿ø»ýµ¿¹°ÀÇ ¹«Æí¸ð ¼¼Æ÷ ³»¿¡ ÀÖ´Ù. ¶ÇÇÑ ÇǺμº ·¹½´¸¶´Ï¾ÆÁõ¿¡¼­ ´ë½Ä ¼¼Æ÷³»¿¡¼­µµ °üÂûµÈ´Ù. L. tro
  • Mooser bodies
    ¹«¿ì¼­ ¼Òü
    ¹ßÁøÆ¼Çª½ºÀÇ ¾î¶² Çü¿¡ À־ Ãʸ· »óÇÇ ¼¼Æ÷ÀÇ »ïÃâ¾×¿¡¼­ °üÂûµÇ´Â ¸®ÄÉÄ¡¾Æ ¸ð¾çÀÇ ¼Òü.
  • Nissl bodies
    ´Ï½½ ¼Òü
    »ö¼Ò ģȭü, ŸÀ̱׷ÎÀÌµå ¹°Áú, Ç¥¹® ¹°Áú. ¿°±â¼º ¿°·á·Î ¿°»öµÇ°í, ³»ÇüÁú ¼¼¸Á°ú ¶óÀ̺¸¼ØÀ¸·Î ±¸¼ºµÈ ½Å°æ ¼¼Æ÷³»ÀÇ Ä¿´Ù¶õ °ú¸³.
  • purine bodies test
    Ǫ¸°Ã¼ ½ÃÇè
  • rice bodies
    ¹Ì¸³Ã¼
    °üÀý°ÇÀ̳ª ¼öȰ¾× ³¶Á¾¾× ¼Ó¿¡ Çü¼ºµÇ´Â ¹Ì¸³»óÀÇ ¼Òü.
  • Schaumann's bodies
    »þÀ¯¸¸Ã¼
    Àû»öÀÌ µµ´Â °¥»öÀÇ °áÀý»ó ¶Ç´Â Á¶°³ ¸ð¾çÀÇ »ç¸£ÄÚÀ̵µ½Ã½º º´º¯¿¡¼­ °üÂûÇÒ ¼ö ÀÖ´Â ¼Òü.
  • ultimobranchial bodies
    ÈÄ»õü
    Á¦ 5Àεγ¶ ȤÀº »õ³¶ÀÇ ¹èÀ¯µµÃ¼·Î¼­, ºÎ°©»ó¼±À» ¿¬ÇÏ¿© °©»ó¼±°ú À¶ÇÕÇÑ´Ù.
  • vermiform bodies
    Ãæ¾ç ¼Òü
    °£ÀÇ ÄíÆÛ ¼¼Æ÷¿¡¼­ º¼ ¼ö ÀÖ´Â ¼¼Æ÷¸·ÀÇ Æ¯ÀÌÇÑ µ¿ ¸ð¾çÀÇ ÇÔ¸ô·Î¼­ ÆòÇื°ú Èñ¹ÌÇÑ È¾¹® »çÀÌ¿¡ Áß¾Ó ¼±»ó ±¸Á¶¸¦ °¡Áö°í ÀÖ´Ù. ÀÌ¿Í À¯»çÇÑ ±¸Á¶¸¦ ¾î¶² Àå±â³»ÀÇ ´ë½Ä¼¼Æ÷¿Í Ç¥ÇÇÀÇ ¶û°Ô¸£Çѽº ¼¼Æ÷¿¡¼­µµ °üÂûÇÒ ¼ö ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
haematoxylin bodies Poorly defined, homogeneous basophilic remnants of whole nuclei, an occasional finding in the fixed tissues of patients with systemic lupus erythematosus, but observed more frequently in the renal glomeruli and the walls of blood vessels, and probably related to the LE phenomenon; so named because of their affinity for haematoxylin stain.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
alum-haematoxylin A purple nuclear stain used in histology; a mixture of an aqueous solution of ammonium alum and an alcoholic solution of haematoxylin which is ripened or oxidised to haematein.
(05 Mar 2000)
Boehmer's haematoxylin An alum type of haematoxylin in which natural ripening occurs in about 8 to 10 days, and the solution is good for many months.
(05 Mar 2000)
Mallory's phosphotungstic acid haematoxylin stain A stain with broad application in cytology and histology; nuclei, mitochrondria, fibrin, neuroglial fibrils, and cross-striations of skeletal and cardiac muscle stain blue; cartilage ground substance, bone reticulum, and elastin appear in shades of yellow-orange and brownish red; also useful for demonstrating abnormal or diseased astrocytes, often in combination with periodic acid-Schiff stain and Luxol fast blue.
Synonym: Mallory's phosphotungstic acid haematoxylin stain.
(05 Mar 2000)
Gomori's chrome alum haematoxylin-phloxine stain <technique> A technique used to demonstrate cytoplasmic granules, after Bouin's or formalin-Zenker fixatives, using oxidised haematoxylin plus phloxine; in the pancreas, beta cells are blue, alpha and delta cells are red, and zymogen granules are red to unstained; in the pituitary, alpha cells are pink, beta cells and chromophobes are gray-blue, and nuclei are purple to blue.
(05 Mar 2000)
chrome alum haematoxylin-phloxine stain <technique> A stain used to demonstrate pancreatic islet cells; alpha cells appear red, beta cells blue or unstained.
(05 Mar 2000)
phosphotungstic acid haematoxylin A stain with broad application in cytology and histology; nuclei, mitochrondria, fibrin, neuroglial fibrils, and cross-striations of skeletal and cardiac muscle stain blue; cartilage ground substance, bone reticulum, and elastin appear in shades of yellow-orange and brownish red; also useful for demonstrating abnormal or diseased astrocytes, often in combination with periodic acid-Schiff stain and Luxol fast blue.
Synonym: Mallory's phosphotungstic acid haematoxylin stain.
(05 Mar 2000)
Weigert's iron haematoxylin stain <technique> A nuclear staining solution containing haematoxylin, ferric chloride, and hydrochloric acid; useful in combination with von Gieson's stain, especially for demonstrating connective tissue elements or Entamoeba histolytica in sections.
(05 Mar 2000)
haematoxylin <chemical> Basophilic stain that gives a blue colour (to the nucleus of a cell for example), commonly used in conjunction with eosin that stains the cytoplasm pink or red. Various modifications of haematoxylin have been developed. The histopathologist's H&E is haematoxylin and eosin.
(18 Nov 1997)
haematoxylin and eosin stain <technique> Probably the most generally useful of all staining methods for tissues; nuclei are stained a deep blue-black with haematoxylin, and cytoplasm is stained pink after counterstaining with eosin, usually in water.
(05 Mar 2000)
haematoxylin-malachite green-basic fuchsin stain <technique> A stain for epoxy resin-extracted sections; semi-thick sections have their plastic dissolved out and the residual tissue is stained sequentially with the various dyes; nuclei and astrocytes are purplish-pink and myelin, lipid droplets, nucleoli, and oligodendrocytes are bright blue-green.
(05 Mar 2000)
haematoxylin-phloxine B stain <technique> A stain for intact epoxy sections; semi-thick sections of plastic-embedded tissues have the following structures stained blue to black; chromatin, nucleoli, basophilic cytoplasm, mitochondria, plasma and nuclear membranes, anisotropic myofibrils, mast cell granules, and elastic membranes of blood vessels; appearing pink to red are collagen fibrils, reticulum, goblet cell mucins, hyalin cartilage matrix, stereocilia, cytoplasm, and erythrocytes; fat droplets and perichondrocyte matrix are green.
(05 Mar 2000)
Harris' haematoxylin An alum type of haematoxylin similar to Delafield's haematoxylin, but which uses chemical ripening to produce oxidation of haematoxylin for immediate use.
(05 Mar 2000)
Heidenhain's iron haematoxylin stain <technique> An iron alum haematoxylin stain used for staining muscle striations and mitotic structures blue-black.
(05 Mar 2000)
Delafield's haematoxylin An alum type of haematoxylin used in histology; natural ripening takes about 2 months and the solution is good for years.
(05 Mar 2000)
iron haematoxylin Unique ferric lakes of haematein that produce deep blue-black stains; useful for studies of cytologic detail, such as chromosomes, spindle fibres, Golgi apparatus, myofibrils, and mitochrondria; also useful to demonstrate Entamoeba histolytica.
See: Heidenhain's iron haematoxylin stain, Weigert's iron haematoxylin stain.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á